It is time for Jon Dudas to show true leadership

Well, it’s four days now since GlaxoSmithKline obtained its injunction preventing the USPTO’s new claims and continuations rules from coming into force. Not being a lawyer I have no idea whether the injunction will turn into something more permanent…

Unlock unlimited access to all IAM content